Market revenue in 2023 | USD 1,140.1 million |
Market revenue in 2030 | USD 1,879.4 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.64% in 2023. Horizon Databook has segmented the North America real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The North American region comprises the U.S. and Canada. North America region accounted for the largest share of the global market in 2022, which can be attributed to significant support from regulatory bodies for using Real-world Evidence (RWE) solutions, and an increase in R&D spending is also anticipated to boost market growth.
Moreover, rising geriatric population and the subsequent increase in prevalence of chronic diseases is a key factor driving growth of this market. In addition, the high share of the region can be attributed to the presence of key players in the U.S. and Canada. Favorable government regulations and increasing number of RWE service providers in the region are anticipated to drive the market further.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account